 |
Articles: Drug Approvals |
Prior Articles
CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
Cryolife, 10/07/09
Free full text
Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 10/07/09
Free full text
Genzyme Receives FDA Complete Response Letter for Clolar
Genzyme, 10/07/09
Free full text
PEGINTRON Receives a Recommendation for Approval from FDA Advisory Committee for a New Application in Melanoma
Enzon Pharmaceuticals, 10/06/09
Free full text
GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT
GlaxoSmithKline, 10/06/09
Free full text
Allos Therapeutics Announces U.S. Availability of FOLOTYN(TM) (pralatrexate injection) for Relapsed or Refractory Peripheral T-Cell Lymphoma
Allos Therapeutics, 10/06/09
Free full text
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Free full text
APP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
American Pharmaceutical Partners, 10/02/09
Free full text
New Drug Approval
American Journal of Nursing, 10/01/09 Pandemic (H1N1) 2009 Influenza Update: GSKs H1N1 Pandemrix vaccine receives European Commission Approval
GlaxoSmithKline, 10/01/09
Free full text
United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food
BioMarin, 10/01/09
Free full text
Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09 Covidien Receives FDA Clearance for its Mallinckrodt(TM) TaperGuard(TM) Evac Endotracheal Tube
Covidien, 10/01/09 Cell Therapeutics Applies for European Orphan Drug Designation for Pixantrone in Aggressive Non-Hodgkins Lymphoma
Cell Therapeutics, 09/30/09
Free full text
Two-Year Efficacy and Safety of AIR Inhaled Insulin in Patients with Type 1 Diabetes: An Open-Label Randomized Controlled Trial
Diabetes Technology & Therapeutics, 09/29/09 Allos Therapeutics' FOLOTYN(TM) First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09
Free full text
Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN(TM) for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Allos Therapeutics, 09/28/09
Free full text
Novartis bronchodilator QAB149 recommended for approval in European Union to treat patients with chronic obstructive pulmonary disease
Novartis, 09/28/09
Free full text
Multaq Recommended for Approval in the European Union
Sanofi-aventis, 09/28/09
Free full text
FDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets
Covidien, 09/28/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|
